Concepedia

Cynthia de Luise

CD

Statistics

Publications

12

Citations

622

H-Index

12

Active since

1999

Affiliations

Pfizer (United States)(Current)

Rutgers, The State University of New Jersey

Aarhus University Hospital

Boehringer Ingelheim (United States)

Boehringer Ingelheim (Germany)

Cynthia de Luise is an author at Pfizer (United States) specializing in medicine, public health, and cardiovascular disease.

ORCID

Top concepts

Publications per year

1999–2021

12

Publications

12

Chronic obstructive pulmonary disease severity and cardiovascular outcomes

Suellen M. Curkendall, Stephan Lanes, Cynthia de Luise et al. · European Journal of Epidemiology · 2006 · 116 citations

, , +3

Comorbidity and mortality following hip fracture: a population-based cohort study

Cynthia de Luise, Michael Brimacombe, Lars Pedersen et al. · Aging Clinical and Experimental Research · 2008 · 106 citations

, , +7

Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study

Cynthia de Luise, Michael Brimacombe, Lars Pedersen et al. · European Journal of Epidemiology · 2007 · 104 citations

, , +9

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease

M. Mostafa Mokhles, Gianluca Trifirò, Jeanne P. Dieleman et al. · Pharmacological Research · 2011 · 55 citations

, , +6

Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia

Gianluca Trifirò, Mostafa M. Mokhles, Jeanne P. Dieleman et al. · Drug Safety · 2011 · 51 citations

, , +7

Rows per page

1–5 of 12